ROTINO GIANLUCA enters KIROMIC BIOPHARMA, INC. with 320K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 10/16/2020ACC: 0001104659-20-115577
DirectorOfficer· CSIO
Since Oct 2020
320K
Baseline shares
100% direct
320K
Direct ownership
1 position
355.90K
Derivative underlying
3 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned320K
Total
320K direct320K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 320K | Direct |
| Total | 320K | 320K direct |
Derivative Holdings3
Restricted Stock Units
DirectUnderlying security
Common Stock
Underlying shares
21.96K
Shares owned
N/A
Exercise price
0
Expiration
—
Exercise window
—
Stock Options
DirectUnderlying security
Common Stock
Underlying shares
147.81K
Shares owned
N/A
Exercise price
6.64
Expiration
—
Exercise window
—
Restricted Stock Units
DirectUnderlying security
Common Stock
Underlying shares
186.13K
Shares owned
N/A
Exercise price
0
Expiration
—
Exercise window
—
Total
Underlying
355.90K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock | 0 | — | — | 21.96K | N/A |
| Stock Options Direct | Common Stock | 6.64 | — | — | 147.81K | N/A |
| Restricted Stock Units Direct | Common Stock | 0 | — | — | 186.13K | N/A |
| Total | 355.90K | 0.00 | ||||